Heterogeneity in the phosphorylation of human death receptors by p42(mapk/erk2)

S K Frankel1, A A Van Linden, D W Riches

  • 1Program in Cell Biology, National Jewish Medical and Research Center, 1400 Jackson Street, Denver, CO 80206, USA.

Insights

p42(MAPK/ERK2) phosphorylates human CD120a and DR3 death receptors, affecting apoptosis signaling. This phosphorylation occurs on specific residues, differentiating receptors based on their response to this kinase.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Immunology

Background:

  • p42(MAPK/ERK2) phosphorylation of murine CD120a inhibits apoptosis initiation.
  • This phosphorylation preserves signaling pathways like NF-kappaB activation.

Purpose of the Study:

  • To investigate if p42(MAPK/ERK2) phosphorylates other human death receptors in the TNF receptor superfamily.
  • To identify which human death receptors are substrates for p42(MAPK/ERK2).

Main Methods:

  • Western blotting and phospho-specific antibodies to detect phosphorylation.
  • Site-directed mutagenesis to identify phosphorylation sites.
  • Analysis of TNF receptor superfamily members including CD120a, DR3, Fas, DR4, and DR5.

Main Results:

  • CD120a and DR3 were significantly phosphorylated by p42(MAPK/ERK2).
  • Fas, DR4, and DR5 were not phosphorylated by p42(MAPK/ERK2).
  • Phosphorylation occurred on Ser/Thr residues in membrane-proximal regions, not death domains, with Ser 253 being a key site on CD120a.

Conclusions:

  • Human death receptors can be categorized based on their susceptibility to p42(MAPK/ERK2)-mediated Ser/Thr phosphorylation.
  • p42(MAPK/ERK2) plays a role in regulating apoptosis signaling through differential phosphorylation of death receptors.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...